Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 10    symbols : BLUE    save search
bluebird bio Provides Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program
Published: 2021-03-10 (Crawled : 12:39) - biospace.com/
BLUE | $0.9601 0.75% 1.9M twitter stocktwits trandingview |
Health Technology
 | | O: 14.21% H: 0.55% C: -5.33%
disease myeloid leukemia gene therapy therapy leukemia gene therapies acute myeloid leukemia aml
Gainers vs Losers
77% 23%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
TPET | $0.4001 22.02% 35M twitter stocktwits trandingview |
n/a
SRFM 4 | $0.6 21.29% 850K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.